Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

by Tegally, Houriiyah , Villafana, Tonya L , Kwatra, Gaurav , du Plessis, Jeanine , Masilela, Mduduzi , Ahmed, Khatija , Baillie, Vicky , Gilbert, Sarah , Bhorat, Qasim E , Groenewald, Marisa , Moore, Penny L , Wibmer, Constantinos K , Pollard, Andrew J , McKenzie, Shakeel , Padayachee, Sherman D , Bhiman, Jinal N , Rhead, Sarah , Barnabas, Shaun L , Izu, Alane , Fairlie, Lee , Patel, Faeezah , de Oliveira, Tulio , Dheda, Keertan , Cutland, Clare L , Hwa, Shi-Hsia , Aley, Parvinder , Pillay, Sureshnee , Molapo, Kgaogelo , Bhorat, As’ad E , Madhi, Shabir A , Durham, Nicholas M , Lambe, Teresa , Masenya, Masebole , Horne, Elizea , Moultrie, Andrew , Koen, Anthonet L , Laubscher, Matt , Voysey, Merryn , Rossouw, Lindie , van Eck, Samuel , Taoushanis, Carol , Kelly, Elizabeth J , Esmail, Aliasgar , Bhikha, Sutika , Oelofse, Suzette , Jose, Aylin , Briner, Carmen , Thombrayil, Asha , Sigal, Alex , Malahleha, Mookho , Rodel, Hylton

in Adenoviridae / Adolescent / Adult / Adverse events / Antibodies / Antibodies, Neutralizing - blood / Antibodies, Neutralizing - physiology / ChAdOx1 nCoV-19 / Clinical trials / Coronaviruses / COVID-19 / COVID-19 - epidemiology / COVID-19 - immunology / COVID-19 - prevention & control / COVID-19 Serological Testing / COVID-19 vaccines / COVID-19 Vaccines - administration & dosage / COVID-19 Vaccines - adverse effects / COVID-19 Vaccines - immunology / Disease resistance / Double-Blind Method / Genomes / HIV / Human immunodeficiency virus / Humans / Immunogenicity, Vaccine / Infections / Laboratories / Middle Aged / Mutation / Original / Placebos / Safety / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / Sodium chloride / South Africa / T-Lymphocytes - physiology / Treatment Failure / Vaccine efficacy / Vaccine Potency / Vaccines / Viruses / Young Adult

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

2021

Confirm

Do you wish to request the book?

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

Tegally, Houriiyah,

Villafana, Tonya L,

Kwatra, Gaurav,

du Plessis, Jeanine,

Masilela, Mduduzi,

Ahmed, Khatija,

Baillie, Vicky,

Gilbert, Sarah,

Bhorat, Qasim E,

Groenewald, Marisa,

Moore, Penny L,

Wibmer, Constantinos K,

Pollard, Andrew J,

McKenzie, Shakeel,

Padayachee, Sherman D,

Bhiman, Jinal N,

Rhead, Sarah,

Barnabas, Shaun L,

Izu, Alane,

Fairlie, Lee,

Patel, Faeezah,

de Oliveira, Tulio,

Dheda, Keertan,

Cutland, Clare L,

Hwa, Shi-Hsia,

Aley, Parvinder,

Pillay, Sureshnee,

Molapo, Kgaogelo,

Bhorat, As’ad E,

Madhi, Shabir A,

Durham, Nicholas M,

Lambe, Teresa,

Masenya, Masebole,

Horne, Elizea,

Moultrie, Andrew,

Koen, Anthonet L,

Laubscher, Matt,

Voysey, Merryn,

Rossouw, Lindie,

van Eck, Samuel,

Taoushanis, Carol,

Kelly, Elizabeth J,

Esmail, Aliasgar,

Bhikha, Sutika,

Oelofse, Suzette,

Jose, Aylin,

Briner, Carmen,

Thombrayil, Asha,

Sigal, Alex,

Malahleha, Mookho,

Rodel, Hylton

2021

Overview

A double-blind randomized trial in South Africa documented poor efficacy of two doses of the ChAdOx1 nCoV-19 vaccine against the B.1.351 variant of SARS-CoV-2 that emerged in South Africa. Infections occurred in 3.2% of placebo recipients and in 2.5% of vaccine recipients. Thirty-nine of the 42 virus isolates were the B.1.351 variant. None of the cases led to hospitalization or death.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

/ Adult

/ Antibodies, Neutralizing - blood

/ Antibodies, Neutralizing - physiology